NCT02622581
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- Pius-Hospital Oldenburg, Germany
Clinical trial condition
Non Small Cell Lung Cancer Stage III
Explore clinical trials studying Non Small Cell Lung Cancer Stage III. Study availability and eligibility vary by location and protocol.
9 public trials
1 recruiting study
Non Small Cell Lung Cancer Stage III trial results
Not Yet Recruiting
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
NCT04465968
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
Not specified
NCT04577638
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Centre Hospitalier de Brest Brest, France
- Centre de Lutte Contre le Cancer François Baclesse Caen, France
- Centre de Lutte contre le Cancer Oscar Lambret Lille, France
- Valérie JOLAINE Rennes, France
NCT03845270
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- CHU Besançon Besançon, France
- CHU de Bordeaux Bordeaux, France
- Caen - CHU Côte de Nacre Caen, France
- Clermont-Ferrand - CHU Clermont-Ferrand, France
NCT03569072
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
Completed
Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC
NCT03055715
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Univ.-Klinik für Strahlentherapie-Radioonkologie Innsbruck, Austria
- Iridium Cancer Network Antwerp, Belgium
- Department of Radiooncology, Charité Campus Mitte und Campus Virchow Berlin Berlin, Germany
- Department of Radiooncology Cologne Cologne, Germany
Active, Not Recruiting
Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment
NCT05382052
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Hospital Universitario De A Coruna A Coruña, Spain
- Hospital General Universitario de Alicante Alicante, Spain
- Hospital Germans Trias I Pujol Badalona, Barcelona, Spain
- Hospital Universitari Quiron Dexeus Barcelona, Spain
Active, Not Recruiting
Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy
NCT04711330
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Kristof Cuppens Hasselt, Flanders, Belgium
- Piet Verkouteren Aalst, Belgium
- Ingel Demedts Roeselare, Belgium
- Lynn Decoster Turnhout, Belgium
Active, Not Recruiting
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
NCT04392505
- Conditions
- Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +12 more
- Locations
-
- North Estonia Medical Centre Tallinn, Estonia
- Oulu University Hospital Oulu, Finland
- Tampere University Hospital Tampere, Finland
- Turku University Hospital Turku, Finland